Parathyroid carcinoma: A review

Head and Neck

Volumn 33, Issue 3, 2011, Pages 429-436

  Owen, Randall P ^a   Silver, Carl E ^b   Pellitteri, Phillip K ^c   Shaha, Ashok R ^d   Devaney, Kenneth O ^e   Werner, Jochen A ^f   Rinaldo, Alessandra ^g   Ferlito, Alfio ^g  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Allegiance Health ^*  (United States)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g UNIVERSITY OF UDINE   (Italy)

Author keywords

hypercalcemia; hyperparathyroidism; parathyroid carcinoma; prognosis; treatment

Indexed keywords

AZIDOTHIMADINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CINACALCET; CYCLIN D1; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FLUOROURACIL; GENE PRODUCT; LOMUSTINE; LOOP DIURETIC AGENT; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PAMIDRONIC ACID; PARATHYROID HORMONE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

CALCIUM BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CAUSE OF DEATH; CELL PROLIFERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE TITRATION; DRUG EFFICACY; FLUID THERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; LONG TERM CARE; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARATHYROID CARCINOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; RADIOFREQUENCY ABLATION; REHYDRATION; REOPERATION; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; VOCAL CORD PARALYSIS;

BIOPSY, NEEDLE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; MALE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79951700481     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21376     Document Type: Review

References (53)

1. Ruda JM, Hollenbeak CS, Stack BC Jr,. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132: 359-372. (Pubitemid 40326684)
2. Hundahl SA, Fleming ID, Fremgen AM, et al. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1999; 86: 538-544. (Pubitemid 29347419)
3. Rao SR, Shaha AR, Singh B, et al. Management of cancer of the parathyroid. Acta Otolaryngol 2002; 122: 448-452. (Pubitemid 34774782)
4. Rawat N, Khetan N, Williams DW, et al. Parathyroid carcinoma. Br J Surg 2005; 92: 1345-1353. (Pubitemid 41546630)
5. Chen JD, Morrison C, Zhang C, et al. Hyperparathyroidism-jaw tumour syndrome. J Intern Med 2003; 253: 634-642. (Pubitemid 36649095)
6. Carpten JD, Robbins CM, Villablanca A, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002; 32: 676-680. (Pubitemid 35435184)
7. Schantz A, Castleman B,. Parathyroid carcinoma. A study of 70 cases. Cancer 1973; 31: 600-605.
8. Pollack S, Goldin RR, Cohen M,. Parathyroid carcinoma. A report of two cases and a review of the literature. Arch Intern Med 1961; 108: 583-587.
9. Shane E,. Clinical review 122. Parathyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 485-493. (Pubitemid 32207447)
10. Holmes EC, Morton DL, Ketcham AS,. Parathyroid carcinoma: a collective review. Ann Surg 1969; 169: 631-640.
11. Castleman B,. Tumors of the parathyroid glands. National Research Council Committee on Pathology, A.F.I.P, Sec. 4, Fasc 15; 1952: 50.
12. Stephenson HU Jr,. Malignant tumors of the parathyroid glands; a review of the literature with report of a case. Arch Surg 1950; 60: 247-266.
13. Bondeson L, Sandelin K, Grimelius L,. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 1993; 17: 820-829. (Pubitemid 23212014)
14. Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck 2004; 26: 716-726. (Pubitemid 39014637)
15. Clayman GL, Gonzalez HE, El-Naggar A, et al. Parathyroid carcinoma: evaluation and interdisciplinary management. Cancer 2004; 100: 900-905. (Pubitemid 38222848)
16. Cohn K, Silverman M, Corrado J, et al. Parathyroid carcinoma: the Lahey Clinic experience. Surgery 1985; 98: 1095-1100. (Pubitemid 16104729)
17. Thompson LD,. Parathyroid carcinoma. Ear Nose Throat J 2009; 88: 722-724.
18. DeLellis RA,. Parathyroid carcinoma: an overview. Adv Anat Pathol 2005; 12: 53-61.
19. Guiter GE, DeLellis RA,. Risk of recurrence or metastases in atypical parathyroid adenomas. Mod Pathol 2002; 15: 115A (abstract).
20. Shaha AR, Shah JP,. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer 1999; 86: 378-380. (Pubitemid 29347397)
21. Subramaniam P, Wilkinson S, Shepherd JJ,. Inactivation of retinoblastoma gene in malignant parathyroid growths: a candidate genetic trigger? Aust N Z J Surg 1995; 65: 714-716.
22. Cryns VL, Thor A, Xu HJ, et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994; 330: 757-761. (Pubitemid 24080222)
23. Anderson BJ, Samaan NA, Vassilopoulou-Sellin R, et al. Parathyroid carcinoma: features and difficulties in diagnosis and management. Surgery 1983; 94: 906-915. (Pubitemid 14208777)
24. Wynne AG, van Heerden J, Carney JA, et al. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine (Baltimore) 1992; 71: 197-205.
25. Kwak JY, Kim EK, Moon HJ, et al. Parathyroid incidentalomas detected on routine ultrasound-directed fine-needle aspiration biopsy in patients referred for thyroid nodules and the role of parathyroid hormone analysis in the samples. Thyroid 2009; 19: 743-748.
26. Gates JD, Benavides LC, Shriver CD, et al. Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy? J Surg Res 2009; 155: 254-260.
27. Schoretsanitis G, Daskalakis M, Melissas J, et al. Parathyroid carcinoma: clinical presentation and management. Am J Otolaryngol 2009; 30: 277-280.
28. Iacobone M, Ruffolo C, Lumachi F, et al. Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 2005; 390: 385-390. (Pubitemid 41253170)
29. Wilkins BJ, Lewis JS,. Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol 2009; 3: 140-149.
30. Kebebew E, Arici C, Duh QY, et al. Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 2001; 136: 878-885. (Pubitemid 32729547)
31. Koh YW, Park JH, Kim JW, et al. Endoscopic hemithyroidectomy with prophylactic ipsilateral central neck dissection via an unilateral axillo-breast approach without gas insufflation for unilateral micropapillary thyroid carcinoma: preliminary report. Surg Endosc 2010; 24: 188-197.
32. Lee KE, Rao J, Youn YK,. Endoscopic thyroidectomy with the da Vinci robot system using the bilateral axillary breast approach (BABA) technique: our initial experience. Surg Laparosc Endosc Percutan Tech 2009; 19: e71-e75.
33. Genden EM,. Parathyroid carcinoma. Oper Tech Otolaryngol Head Neck Surg 2009; 20: 79-81.
34. Busaidy NL, Jimenez C, Habra MA, et al. Two decades of experience with parathyroid carcinoma. Proc Am Soc Clin Oncol 2003; 22: 516 (abstract).
35. Yarbrough DE, Thompson GB, Kasperbauer JL, et al. Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery 2004; 136: 1107-1115. (Pubitemid 39647523)
36. Munson ND, Foote RL, Northcutt RC, et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 2003; 98: 2378-2384. (Pubitemid 37466652)
37. Calandra DB, Chejfec G, Foy BK, et al. Parathyroid carcinoma: biochemical and pathologic response to DTIC. Surgery 1984; 96: 1132-1137.
38. Bukowski RM, Sheeler L, Cunningham J, et al. Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med 1984; 144: 399-400. (Pubitemid 14186837)
39. Chahinian AP, Holland JF, Nieburgs HE, et al. Metastatic nonfunctioning parathyroid carcinoma: ultrastructural evidence of secretory granules and response to chemotherapy. Am J Med Sci 1981; 282: 80-84. (Pubitemid 12233841)
40. Fassnacht M, Kreissl MC, Weismann D, et al. New targets and therapeutic approaches for endocrine malignancies. Pharmacol Ther 2009; 123: 117-141.
41. Fernandez-Ranvier GG, Khanafshar E, Tacha D, et al. Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer 2009; 115: 334-344.
42. Gill AJ, Clarkson A, Gimm O, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 2006; 30: 1140-1149. (Pubitemid 44299347)
43. Hsi ED, Zukerberg LR, Yang WI, et al. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 1996; 81: 1736-1739. (Pubitemid 26152455)
44. Vasef MA, Brynes RK, Sturm M, et al. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol 1999; 12: 412-416. (Pubitemid 29203331)
45. Falchetti A, Becherini L, Martineti V, et al. Telomerase repeat amplification protocol (TRAP): a new molecular marker for parathyroid carcinoma. Biochem Biophys Res Commun 1999; 265: 252-255.
46. Falchetti A, Franchi A, Bordi C, et al. Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture. J Bone Miner Res 2005; 20: 410-418. (Pubitemid 40293489)
47. Schott M, Feldkamp J, Schattenberg D, et al. Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. Eur J Endocrinol 2000; 142: 300-306. (Pubitemid 30176941)
48. Glover DJ, Shaw L, Glick JH, et al. Treatment of hypercalcemia in parathyroid cancer with WR-2721, S-2-(3-aminopropylamino)ethyl-phosphorothioic acid. Ann Intern Med 1985; 103: 55-57. (Pubitemid 15068500)
49. Koyano H, Shishiba Y, Shimizu T, et al. Successful treatment by surgical removal of bone metastasis producing PTH: new approach to the management of metastatic parathyroid carcinoma. Intern Med 1994; 33: 697-702. (Pubitemid 24366430)
50. Artinyan A, Guzman E, Maghami E, et al. Metastatic parathyroid carcinoma to the liver treated with radiofrequency ablation and transcatheter arterial embolization. J Clin Oncol 2008; 26: 4039-4041.
51. Silverberg SJ, Rubin MR, Faiman C, et al. Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab 2007; 92: 3803-3808. (Pubitemid 47607626)
52. Koea JB, Shaw JHF,. Parathyroid cancer: biology and management. Surg Oncol 1999; 8: 155-165.
53. Okamoto T, Iihara M, Obara T, et al. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surg 2009; 33: 2343-2354.